INS and type 2 diabetes mellitus: There is often a delay in initiation and titration of basal insulin (BI) in people with type 2 diabetes mellitus (T2DM) inadequately controlled by non‐insulin treatment.1, 2 Lack of time and resources for healthcare providers (HCPs), complexity of the titration process, fear of hypoglycaemia,3, 4, 5 along with psychological barriers to the idea itself of insulin initiation, are the most common reasons of such a delay.